About National Research Corporation (NASDAQ:NRCIB)
National Research Corporation provides analytics and insights for the patient and employee experience in serving the healthcare providers, payers, and other healthcare organizations in the United States and Canada. Its portfolio of subscription-based solutions offer information and analysis services in a range of elements, including patient experience and satisfaction, community population health risks, workforce engagement, community perceptions, and physician engagement. The company offers Market Insights solutions that allow the tracking of awareness, perception, and consistency of healthcare brands; assessment of competitive differentiators; and enhanced segmentation tools to evaluate the needs, wants, and behaviors of communities through real-time competitive assessments and enhanced segmentation tools. It also provides Experience solutions, such as patient and resident experience, workforce engagement, health risk assessments, transitions, and improvement tools. In addition, the company offers Transitions solutions, which enable organizations to identify and manage high-risk patients to reduce readmissions, increase patient satisfaction, and support safe care transitions; and Risk Assessment solutions that enables clients to segment populations and manage care for those who are most at-risk, engage individuals, enhance preventative care, and manage wellness programs. Further, it provides Transparency Solutions, which allow healthcare organizations to share a picture of their organization and ensure that content informs in consumer decision-making; and Governance Solutions, which are membership services for not-for-profit hospital and health system boards of directors, executives, and physician leadership. The company serves integrated health systems and post-acute providers, such as home health, long term care, and hospice, as well as payer organizations. National Research Corporation was founded in 1981 and is headquartered in Lincoln, Nebraska.
Industry, Sector and Symbol:
- Industry: Research Services
- Sub-Industry: Health Care Services
- Sector: Business Services
- Symbol: NASDAQ:NRCIB
- CUSIP: 63737230
- Web: United States
- Current Ratio: 1.58%
- Quick Ratio: 1.58%
Sales & Book Value:
- Trailing P/E Ratio: 74.7
- Forward P/E Ratio: 54.35
- Annual Sales: $109.38 million
- Price / Sales: 11.92
- Cash Flow: $1.32 per share
- Price / Cash: 40.37
- Book Value: $3.63 per share
- Price / Book: 14.67
- Annual Dividend: $2.40
- Dividend Yield: 4.5%
- Trailing EPS: $0.50
- Net Income: $20.51 million
- Net Margins: 19.09%
- Return on Equity: 30.84%
- Return on Assets: 21.29%
- Employees: 404
- Outstanding Shares: 24,480,000
Frequently Asked Questions for National Research Corporation (NASDAQ:NRCIB)
What is National Research Corporation's stock symbol?
National Research Corporation trades on the NASDAQ under the ticker symbol "NRCIB."
How often does National Research Corporation pay dividends? What is the dividend yield for National Research Corporation?
National Research Corporation announced a quarterly dividend on Tuesday, September 5th. Stockholders of record on Friday, September 29th will be given a dividend of $0.60 per share on Friday, October 13th. This represents a $2.40 annualized dividend and a dividend yield of 4.51%. The ex-dividend date is Thursday, September 28th. View National Research Corporation's Dividend History.
How were National Research Corporation's earnings last quarter?
National Research Corporation (NASDAQ:NRCIB) released its quarterly earnings data on Thursday, May, 4th. The business services provider reported $0.26 earnings per share for the quarter, missing the Thomson Reuters' consensus estimate of $0.81 by $0.55. The business services provider had revenue of $30.28 million for the quarter. National Research Corporation had a net margin of 19.09% and a return on equity of 30.84%. View National Research Corporation's Earnings History.
When will National Research Corporation make its next earnings announcement?
Where is National Research Corporation's stock going? Where will National Research Corporation's stock price be in 2017?
1 equities research analysts have issued 12-month price objectives for National Research Corporation's shares. Their predictions range from $44.00 to $44.00. On average, they expect National Research Corporation's share price to reach $44.00 in the next year. View Analyst Ratings for National Research Corporation.
Who are some of National Research Corporation's key competitors?
Some companies that are related to National Research Corporation include CEB (CEB), Sotheby's (BID), Topcon Corp (TOPCF), Convergys Corporation (CVG), Pagegroup Plc (MPGPF), Advanced Disposal Services (ADSW), SouFun Holdings Limited (SFUN), Herman Miller (MLHR), Exponent (EXPO), comScore (SCOR), Steelcase (SCS), Sykes Enterprises, Incorporated (SYKE), Yext (YEXT), Kelly Services (KELYA), Mitie Group PLC. (MITFY), Houghton Mifflin Harcourt Company (HMHC), ICF International (ICFI) and Tessera Holding Corporation (XPER).
Who owns National Research Corporation stock?
Who sold National Research Corporation stock? Who is selling National Research Corporation stock?
Who bought National Research Corporation stock? Who is buying National Research Corporation stock?
How do I buy National Research Corporation stock?
Shares of National Research Corporation can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is National Research Corporation's stock price today?
One share of National Research Corporation stock can currently be purchased for approximately $53.26.
How big of a company is National Research Corporation?
National Research Corporation has a market capitalization of $1.29853 billion and generates $109.38 million in revenue each year. The business services provider earns $20.51 million in net income (profit) each year or $0.50 on an earnings per share basis. National Research Corporation employs 404 workers across the globe.
How can I contact National Research Corporation?
National Research Corporation's mailing address is 1245 Q STREET, LINCOLN NE, 68508. The business services provider can be reached via phone at 402-475-2525.
MarketBeat Community Rating for National Research Corporation (NASDAQ NRCIB)MarketBeat's community ratings are surveys of what our community members think about National Research Corporation and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.
Analysts' Consensus Rating for National Research Corporation (NASDAQ:NRCIB) (How are Consensus Ratings Calculated?)
MarketBeat calculates consensus analyst ratings for company stocks using the most recent rating from each brokerage that has rated a stock within the last twelve months. Since brokers often use different ratings systems, each rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months.
MarketBeat will no longer include ratings and price target data in its consensus calculation if a broker drops coverage and MarketBeat has received a report that coverage was dropped. Ratings from certain research firms that issue ratings using purely quantitative methods (such as Zacks, Vetr and ValuEngine) are not included in consensus calculations. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
|Ratings Breakdown: ||0 Sell Ratings, 1 Hold Rating, 0 Buy Ratings, 0 Strong Buy Ratings|
|Consensus Rating:||Hold (Score: 2.00)|
|Consensus Price Target: ||$44.00 (17.39% downside)|
Consensus Price Target History for National Research Corporation (NASDAQ:NRCIB)
Analysts' Ratings History for National Research Corporation (NASDAQ:NRCIB)
(Data available from 11/18/2015 forward)
|Date||Firm||Action||Rating||Price Target||Impact on Share Price||Details|
|2/16/2017||First Analysis||Downgrade||Overweight -> Equal Weight||$44.00||N/A|
Earnings History and Estimates Chart for National Research Corporation (NASDAQ:NRCIB)
Earnings History by Quarter for National Research Corporation (NASDAQ NRCIB)
(Data available from 1/1/2011 forward)
|Date||Quarter||Consensus Estimate||Actual EPS||Revenue Estimate||Actual Revenue||Release Link||Conference Call||Details|
|5/4/2017||Q1 2017||$0.81||$0.26||$30.28 million||View||Listen|
|2/14/2017||Q4 2016||$0.22||$0.23||$28.37 million||View||N/A|
|8/4/2015||Q1||$0.22||$0.21||$25.00 million||$24.46 million||View||N/A|
|5/7/2015||Q1 2015||$0.22||$0.08||$27.10 million||$26.27 million||View||N/A|
|2/10/2015||Q4 2014||$0.18||$0.17||$25.12 million||View||N/A|
|11/4/2014||Q3 2014||$0.18||$0.19||$24.40 million||$23.68 million||View||N/A|
|5/6/2014||Q1||$0.20||$0.77||$26.28 million||$26.03 million||View||Listen|
Earnings Estimates for National Research Corporation (NASDAQ:NRCIB)
2017 EPS Consensus Estimate: $2.14
(Data provided by Zacks Investment Research)
|Quarter||Number of Estimates||Low Estimate||High Estimate||Average Estimate|
Current Dividend Information for National Research Corporation (NASDAQ:NRCIB)
|Most Recent Dividend:||10/13/2017|
|Payout Ratio:||480.00% (Trailing 12 Months of Earnings) |
244.90% (Based on This Year's Estimates)
218.18% (Based on Next Year's Estimates)
Dividend History by Quarter for National Research Corporation (NASDAQ NRCIB)
(Data available from 1/1/2013 forward)
|Announced||Period||Amount||Yield||Ex-Dividend Date||Record Date||Payable Date|
Insider Trading and Institutional Ownership History for National Research Corporation (NASDAQ NRCIB)
Insider Ownership Percentage: 39.09%
Institutional Ownership Percentage: 2.58%
Insider Trades by Quarter for National Research Corporation (NASDAQ NRCIB)
(Data available from 1/1/2013 forward)
|Transaction Date||Insider Name||Title||Buy/Sell||Number of Shares||Average Share Price||Total Transaction||Details|
|1/17/2017||Michael D Hays||CEO||Sell||4,296||$18.32||$78,702.72|| |
|1/13/2017||Michael D Hays||CEO||Sell||10,000||$18.55||$185,500.00|| |
|9/21/2016||Michael D Hays||CEO||Sell||1,440||$16.01||$23,054.40|| |
|9/20/2016||Michael D Hays||CEO||Sell||1,500||$16.28||$24,420.00|| |
|9/19/2016||Michael D Hays||CEO||Sell||3,533||$16.19||$57,199.27|| |
|6/29/2015||Michael D Hays||CEO||Sell||4,000||$14.50||$58,000.00|| |
|3/24/2015||Michael D Hays||CEO||Sell||1,624||$15.03||$24,408.72|| |
|3/23/2015||Michael D Hays||CEO||Sell||18,026||$23.35||$420,907.10|| |
|2/25/2015||Michael D Hays||CEO||Sell||1,195||$14.00||$16,730.00|| |
|2/24/2015||Michael D Hays||CEO||Sell||11,561||$14.00||$161,854.00|| |
|2/23/2015||Michael D Hays||CEO||Sell||48,892||$14.00||$684,488.00|| |
|1/5/2015||Michael D Hays||CEO||Sell||700||$35.07||$24,549.00|| |
|12/31/2014||Michael D Hays||CEO||Sell||5,051||$14.00||$70,714.00|| |
|12/30/2014||Michael D Hays||CEO||Sell||2,142||$14.00||$29,988.00|| |
|12/29/2014||Michael D Hays||CEO||Sell||3,686||$14.00||$51,604.00|| |
|11/26/2014||Michael D Hays||CEO||Sell||1,000||$15.00||$15,000.00|| |
|11/25/2014||Michael D Hays||CEO||Sell||4,059||$15.42||$62,589.78|| |
Headline Trends for National Research Corporation (NASDAQ:NRCIB)
Latest Headlines for National Research Corporation (NASDAQ NRCIB)
Financials are not available for this stock.
National Research Corporation (NASDAQ NRCIB) Chart for Saturday, November, 18, 2017